MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Galectin Therapeutics Inc.

GALT

#3069
Galectin Therapeutics Inc. - Common Stock
4.0 2 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
4.02
4.02
Year Range
2.03
7.13
Daily Change
-2.90%
Monthly Change
+14.53%
6 month change
+34.90%
Year Change
-6.07%
Previous Close
4.1 4
Open
4.0 2
Low
4.0 2
High
4.0 2
Volume
40
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. GALT
Open full chart

Financials

Overview Statement Statistics Documents

2002

Current report, Q1 FY2002
2002.02.25
GALECTIN THERAPEUTICS INC current report, Q1 FY2002
8-K
  • 1
  • ...
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41

News

Benzinga
NRIX GALT
2026.06.30
Top 3 Health Care Stocks That May Keep You Up At Night In June - Nurix Therapeutics (NASDAQ:NRIX), Galect
Seeking Alpha
GALT
2026.06.24
Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside
Zacks
GALT LQDA IMCR INDV
2026.06.24
GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH
Zacks
GALT
2026.04.03
Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock?
Investing
GALT
2026.03.17
Galectin Therapeutics appoints Johns Hopkins neurosurgeon to board
Seeking Alpha
GALT
2026.03.10
Galectin Therapeutics Inc. (GALT) Discusses Updated Results for Belapectin in Treatment of MASH Cirrhosis and Portal Hypertension Transcript
Investing
GALT
2026.01.12
Galectin Therapeutics director Marc Rubin resigns from board
Investing
GALT
2026.01.07
Galectin Therapeutics CFO sells $233k in shares
Seeking Alpha
GALT
2025.12.24
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
Investing
CAT ORCL AMAT LRCX NVDA
2025.12.19
oracle, micron tech among market cap stock movers on friday
Investing
GALT
2025.12.19
Galectin Therapeutics stock plummets after FDA feedback on drug
Investing
GALT
2025.12.19
FDA provides feedback on Galectin’s belapectin development program

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd